News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
LAWLIS V BRYAN
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/02/2023 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 125,000 options to buy
@ $3.27, valued at
$408.8k
|
|
05/24/2023 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 4,190 shares
@ $0 |
|
05/11/2023 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on GERON CORP
Txns:
| Sold 35,000 shares
@ $3, valued at
$105k
Exercised 35,000 options to buy
@ $1.1, valued at
$38.5k
|
|
04/04/2023 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 8,500 shares
@ $97.09, valued at
$825.3k
Exercised 8,500 options to buy
@ $67.81, valued at
$576.4k
|
|
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/18/2022 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 4,250 shares
@ $83.66, valued at
$355.6k
Exercised 4,250 options to buy
@ $37.46, valued at
$159.2k
|
|
01/19/2022 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 4,250 shares
@ $87.61, valued at
$372.3k
Exercised 4,250 options to buy
@ $37.46, valued at
$159.2k
|
|
06/09/2021 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $6.8, valued at
$272k
|
|
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2021 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on Coherus BioSciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $17.58, valued at
$351.6k
|
|
06/10/2020 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns:
| Granted 28,100 options to buy
@ $8.89, valued at
$249.8k
|
|
06/09/2020 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 83,000 options to buy
@ $1.54, valued at
$127.8k
|
|
06/09/2020 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 4,430 shares
@ $107.46, valued at
$476k
|
|
05/29/2020 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 4,300 shares
@ $0 |
|
03/18/2020 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 4,610 shares
@ $76.52, valued at
$352.8k
Sold 3,750 shares
@ $75.39, valued at
$282.7k
Exercised 3,750 options to buy
@ $21.51, valued at
$80.7k
|
|
01/14/2020 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on Coherus BioSciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $17.73, valued at
$354.6k
|
|
12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/18/2019 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 3,750 shares
@ $74.47, valued at
$279.3k
Exercised 3,750 options to buy
@ $21.51, valued at
$80.7k
|
|
06/19/2019 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 3,750 shares
@ $81.08, valued at
$304.1k
Exercised 3,750 options to buy
@ $21.51, valued at
$80.7k
|
|
06/07/2019 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on GERON CORP
Txns:
| Granted 70,000 options to buy
@ $1.38, valued at
$96.6k
|
|
06/07/2019 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns:
| Granted 12,400 options to buy
@ $6.33, valued at
$78.5k
|
|
06/06/2019 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 4,430 shares
@ $0 |
|
03/29/2019 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 2,150 shares
@ $89.76, valued at
$193k
Exercised 2,150 options to buy
@ $14.39, valued at
$30.9k
|
|
01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2018 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 2,150 shares
@ $82.53, valued at
$177.4k
Exercised 2,150 options to buy
@ $14.39, valued at
$30.9k
|
|
09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/17/2018 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns:
| Granted 36,800 options to buy
@ $8.78, valued at
$323.1k
|
|
06/29/2018 |
4
| LAWLIS V BRYAN (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 2,150 shares
@ $93.52, valued at
$201.1k
Exercised 2,150 options to buy
@ $14.39, valued at
$30.9k
|
|
|
|
|